MedPath

陕西天宇制药有限公司

Ownership
-
Established
1999-09-23
Employees
-
Market Cap
-
Website
http://www.tytiu.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

7

NMPA:7

Drug Approvals

Argatroban Injection

Product Name
阿加曲班注射液
Approval Number
国药准字H20254460
Approval Date
Jun 3, 2025
NMPA

Levetiracetam Oral Solution

Product Name
左乙拉西坦口服溶液
Approval Number
国药准字H20253937
Approval Date
Apr 15, 2025
NMPA

Lauromacrogol Injection

Product Name
聚桂醇注射液
Approval Number
国药准字H20080445
Approval Date
Sep 9, 2022
NMPA

Lauromacrogol

Product Name
聚桂醇
Approval Number
国药准字H20080330
Approval Date
Sep 9, 2022
NMPA

Amikacin Sulfate Injection

Product Name
硫酸阿米卡星注射液
Approval Number
国药准字H61020059
Approval Date
May 13, 2020
NMPA

Amikacin Sulfate Injection

Product Name
硫酸阿米卡星注射液
Approval Number
国药准字H61020058
Approval Date
May 13, 2020
NMPA

Amoxicillin Capsules

Product Name
阿莫西林胶囊
Approval Number
国药准字H61020539
Approval Date
Sep 13, 2002
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.